Ex vivo Murine Thromboinflammation Model with Validation on EMT-6 Breast Cancer
- 作者: Korobkina J.D.1, Mishukov A.A.1, Osidak E.O.2, Sveshnikova A.N.1,2
-
隶属关系:
- Center for Theoretical Problems of Physicochemical Pharmacology of the RAS
- Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
- 期: 卷 111, 编号 2 (2025)
- 页面: 266-277
- 栏目: EXPERIMENTAL ARTICLES
- URL: https://edgccjournal.org/0869-8139/article/view/679308
- DOI: https://doi.org/10.31857/S0869813925020057
- EDN: https://elibrary.ru/UIWBQP
- ID: 679308
如何引用文章
详细
Thromboinflammation is a complex interaction between the hemostasis system and the immune system associated with the participation of neutrophils in the process of thrombosis. An imbalance in the mutual activation of platelets and neutrophils in various pathologies leads to thrombosis or bleeding. Previously, we developed a technique for ex vivo observation of the process of thrombosis and chemotaxis of neutrophils in parallel-plate flow chambers coated with fibrillar collagen. The aim of this work was to develop a technique for ex vivo observation of the thromboinflammation process in mice, which allows analyzing the interaction of polymorphonuclear leukocytes (PMN) with growing blood clots. To validate the technique, a breast cancer model was used in BALB/c mice (7 days after orthotopic inoculation with EMT-6 tumor cell culture). In the blood samples of healthy mice, blood clots formed on fibrillar collagen, however, nuclear cells were not observed. The use of a combination of fibronectin and collagen as a substrate made it possible to induce thrombosis and monitor the movement and behavior of PMNs in the vicinity of blood clots. Using the developed model, it was shown that in breast cancer, the growth of blood clots is slowed down – the relative size of blood clots in breast cancer is 21 ± 11% of the field of view compared with 39 ± 10% in healthy mice. At the same time, the number of PMNs adhering to blood clots and the speed of their movement on the substrate do not differ in healthy mice and mice with tumors. However, the number of PMNs leaving the thrombus and sliding onto the fibronectin-collagen matrix was significantly increased in mice with a tumor (39 ± 23 versus 15 ± 8 in healthy controls). Thus, using the developed thromboinflammation model, it is shown that already at the early stages of tumor development, violations of the thromboinflammation process are observed.
全文:

作者简介
J. J. Korobkina
Center for Theoretical Problems of Physicochemical Pharmacology of the RAS
编辑信件的主要联系方式.
Email: asve6nikova@yandex.ru
俄罗斯联邦, Moscow
A. Mishukov
Center for Theoretical Problems of Physicochemical Pharmacology of the RAS
Email: asve6nikova@yandex.ru
俄罗斯联邦, Moscow
E. Osidak
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Email: asve6nikova@yandex.ru
俄罗斯联邦, Moscow
A. Sveshnikova
Center for Theoretical Problems of Physicochemical Pharmacology of the RAS; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Email: asve6nikova@yandex.ru
俄罗斯联邦, Moscow; Moscow
参考
- Darbousset R, Mezouar S, Dignat-George F, Panicot-Dubois L, Dubois C (2014) Involvement of neutrophils in thrombus formation in living mice. Pathol Biol 62: 1–9. https://doi.org/10.1016/j.patbio.2013.11.002
- Italiano Jr JE, Battinelli EM (2009) Selective sorting of alpha-granule proteins. J Thromb Haemost 7: 173–176. https://doi.org/10.1111/j.1538-7836.2009.03387.x
- Parsons MEM, Szklanna PB, Guerrero JA, Wynne K, Dervin F, O’Connell K, Allen S, Egan K, Bennett C, McGuigan C, Gheveart C, Ní Áinle F, Maguire PB (2018) Platelet releasate proteome profiling reveals a core set of proteins with low variance between healthy adults. Proteomics 18: 1800219. https://doi.org/10.1002/pmic.201800219
- Sveshnikova AN, Adamanskaya EA, Panteleev MA (2024) Conditions for the implementation of the phenomenon of programmed death of neutrophils with the appearance of DNA extracellular traps during thrombus formation. Pediatr Hematol Immunopathol 23: 211–218. https://doi.org/10.24287/1726-1708-2024-23-1-211-218
- Schönichen C, Montague SJ, Brouns SLN, Burston JJ, Cosemans JMEM, Jurk K, Kehrel BE, Koenen RR, Ní Áinle F, O’Donnell VB, Soehnlein O, Watson SP, Kuijpers MJE, Heemskerk JWM, Nagy M (2023) Antagonistic roles of human platelet integrin αIIbβ3 and chemokines in regulating neutrophil activation and fate on arterial thrombi under flow. Arterioscler Thromb Vasc Biol 43: 1700–1712. https://doi.org/10.1161/ATVBAHA.122.318767
- Morozova DS, Martyanov AA, Obydennyi SI, Korobkin J-JD, Sokolov AV, Shamova EV, Gorudko IV, Khoreva AL, Shcherbina A, Panteleev MA, Sveshnikova AN (2022) Ex vivo observation of granulocyte activity during thrombus formation. BMC Biol 20: 32. https://doi.org/10.1186/s12915-022-01238-x
- Nechipurenko DY, Receveur N, Yakimenko AO, Shepelyuk TO, Yakusheva AA, Kerimov RR, Obydennyy SI, Eckly A, Léon C, Gachet C, Grishchuk EL, Ataullakhanov FI, Mangin PH, Panteleev MA (2019) Clot Contraction Drives the Translocation of Procoagulant Platelets to Thrombus Surface. Arterioscler Thromb Vasc Biol 39: 37–47. https://doi.org/10.1161/ATVBAHA.118.311390
- Schattner M, Jenne CN, Negrotto S, Ho-Tin-Noe B (2020) editorial: Platelets and immune responses during thromboinflammation. Front Immunol 11: 1079. https://doi.org/10.3389/fimmu.2020.01079
- Sveshnikova AN, Tesakov IP, Kuznetsova SA, Shamova ЕМ (2024) Role of platelet activation in the development and metastasis of solid tumors. J Evol Biochem Physiol 60: 211–227. https://doi.org/10.1134/S0022093024010150
- Sohal S, Thakur A, Zia A, Sous M, Trelles D (2020) Disseminated intravascular coagulation and malignancy: A case report and literature review. Case Rep Oncol Med 2020: 1–5. https://doi.org/10.1155/2020/9147105
- Li B, Lu Z, Yang Z, Zhang X, Wang M, Chu T, Wang P, Qi F, Anderson GJ, Jiang E, Song Z, Nie G, Li S (2023) Monitoring circulating platelet activity to predict cancer-associated thrombosis. Cell Rep Methods 3: 100513. https://doi.org/10.1016/j.crmeth.2023.100513
- De Meo ML, Spicer JD (2021) The role of neutrophil extracellular traps in cancer progression and metastasis. Semin Immunol 57: 101595. https://doi.org/10.1016/j.smim.2022.101595
- Kakumoto A (2024) Prognostic impact of tumor-associated neutrophils in breast cancer. Int J Clin Exp Pathol 17: 51–62. https://doi.org/10.62347/JQDQ1527
- Taucher E, Taucher V, Fink-Neuboeck N, Lindenmann J, Smolle-Juettner F-M (2021) role of tumor-associated neutrophils in the molecular carcinogenesis of the lung. Cancers 13: 5972. https://doi.org/10.3390/cancers13235972
- Jin L, Kim HS, Shi J (2021) Neutrophil in the pancreatic tumor microenvironment. Biomolecules 11: 1170. https://doi.org/10.3390/biom11081170
- Margaroli C, Cardenas MA, Jansen CS, Moon Reyes A, Hosseinzadeh F, Hong G, Zhang Y, Kissick H, Tirouvanziam R, Master VA (2020) The immunosuppressive phenotype of tumor-infiltrating neutrophils is associated with obesity in kidney cancer patients. OncoImmunology 9: 1747731. https://doi.org/10.1080/2162402X.2020.1747731
- Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM (2009) Polarization of tumor-associated neutrophil phenotype by TGF-β: «N1» versus «N2» TAN. Cancer Cell 16: 183–194. https://doi.org/10.1016/j.ccr.2009.06.017
- Schaider H, Oka M, Bogenrieder T, Nesbit M, Satyamoorthy K, Berking C, Matsushima K, Herlyn M (2003) Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8. Int J Cancer 103: 335–343. https://doi.org/10.1002/ijc.10775
- Musiani P, Allione A, Modica A, Lollini PL, Giovarelli M, Cavallo F, Belardelli F, Forni G, Modesti A (1996) Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Investig J Tech Methods Pathol 74: 146–157
- Martyanov AA, Morozova DS, Sorokina MA, Filkova AA, Fedorova DV, Uzueva SS, Suntsova EV, Novichkova GA, Zharkov PA, Panteleev MA, Sveshnikova AN (2020) Heterogeneity of integrin αIIbβ3 function in pediatric immune thrombocytopenia revealed by continuous flow cytometry analysis. Int J Mol Sci 21: 3035. https://doi.org/10.3390/ijms21093035
- Martyanov AA, Tesakov IP, Khachatryan LA, An OI, Boldova AE, Ignatova AA, Koltsova EM, Korobkin J-JD, Podoplelova NA, Svidelskaya GS, Yushkova E, Novichkova GA, Eble JA, Panteleev MA, Kalinin DV, Sveshnikova AN (2023) Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon. Blood Adv 7: 4936–4949. https://doi.org/10.1182/bloodadvances.2022009590
- Korobkin J-JD, Deordieva EA, Tesakov IP, Adamanskaya E-IA, Boldova AE, Boldyreva AA, Galkina SV, Lazutova DP, Martyanov AA, Pustovalov VA, Novichkova GA, Shcherbina A, Panteleev MA, Sveshnikova AN (2024) Dissecting thrombus-directed chemotaxis and random movement in neutrophil near-thrombus motion in flow chambers. BMC Biol 22: 115. https://doi.org/10.1186/s12915-024-01912-2
- Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, Damti P, Lumbroso D, Polyansky L, Sionov RV, Ariel A, Hovav A-H, Henke E, Fridlender ZG, Granot Z (2015) Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep 10: 562–573. https://doi.org/10.1016/j.celrep.2014.12.039
- Tucker EI, Verbout NG, Leung PY, Hurst S, McCarty OJT, Gailani D, Gruber A (2012) Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis. Blood 119: 4762–4768. https://doi.org/10.1182/blood-2011-10-386185
- Jackson SP, Darbousset R, Schoenwaelder SM (2019) Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood 133: 906–918. https://doi.org/10.1182/blood-2018-11-882993
- Mishukov AA, Gaur S, Adamanskaya E-IA, Panteleev M, Sveshnikova AN (2024) Evaluation of platelet functional activity in healthy BALB/c mice and in EMT-6 breast cancer orthotopic model. J Evol Biochem Physiol 61.
- Tavera-Mendoza LE, Brown M (2017) A less invasive method for orthotopic injection of breast cancer cells into the mouse mammary gland. Lab Anim 51: 85–88. https://doi.org/10.1177/0023677216640706
- Pulikkot S, Hu L, Chen Y, Sun H, Fan Z (2022) Integrin regulators in neutrophils. Cells 11: 2025. https://doi.org/10.3390/cells11132025
- Ingham KC, Brew SA, Isaacs BS (1988) Interaction of fibronectin and its gelatin-binding domains with fluorescent-labeled chains of type I collagen. J Biol Chem 263: 4624–4628. https://doi.org/10.1016/S0021-9258(18)68828-3
- Ni H, Yuen PST, Papalia JM, Trevithick JE, Sakai T, Fässler R, Hynes RO, Wagner DD (2003) Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci U S A 100: 2415–2419. https://doi.org/10.1073/pnas.2628067100
- Everitt EA, Malik AB, Hendey B (1996) Fibronectin enhances the migration rate of human neutrophils in vitro. J Leukoc Biol 60: 199–206. https://doi.org/10.1002/jlb.60.2.199
- Boneschansker L, Jorgensen J, Ellett F, Briscoe DM, Irimia D (2018) Convergent and divergent migratory patterns of human neutrophils inside microfluidic mazes. Sci Rep 8: 1887. https://doi.org/10.1038/s41598-018-20060-6
- Trivanović D, Mojsilović S, Bogosavljević N, Jurišić V, Jauković A (2024) Revealing profile of cancer-educated platelets and their factors to foster immunotherapy development. Transl Oncol 40: 101871. https://doi.org/10.1016/j.tranon.2023.101871
- Kawano T, Hisada Y, Grover SP, Schug WJ, Paul DS, Bergmeier W, Mackman N (2023) Decreased platelet reactivity and function in a mouse model of human pancreatic cancer. Thromb Haemost 123: 501–509. https://doi.org/10.1055/s-0043-1761419
- Biermann H, Pietz B, Dreier R, Schmid KW, Sorg C, Sunderkötter C (1999) Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J Leukoc Biol 65: 217–231. https://doi.org/10.1002/jlb.65.2.217
- Gruijs M, Sewnath CAN, Van Egmond M (2021) Therapeutic exploitation of neutrophils to fight cancer. Semin Immunol 57: 101581. https://doi.org/10.1016/j.smim.2021.101581
- Brewer G (2023) Activated neutrophils: the anti-hero. Nat Rev Cancer 23: 190. https://doi.org/10.1038/s41568-023-00555-9
补充文件
